Latest Cost Savings News

Genesis Minerals and Vault Minerals have agreed to merge, creating a top-3 Australian gold producer with a pro-forma market cap of about A$12.66 billion and annual production of 600-700koz.

Genesis Minerals and Vault Minerals have agreed to merge in a deal valuing Vault at about A$5.6 billion, creating a top-three Australian gold producer with pro-forma annual production of 600-700koz and estimated synergies of A$2 billion.

Adrad Holdings is investing $3 million to build a second factory in Thailand, aiming to boost capacity for its Heat Transfer Solutions business and streamline operations.

Anson Resources has clinched approval for its Small Scale Mining Operation at its Green River Lithium Project, clearing the way for a 10,000 tpa lithium carbonate plant in Utah. With all major permits in hand, the company moves closer to refining costs and advancing project financing.

Southern Palladium’s latest DFS metallurgical tests reveal a dramatic jump in chromite recovery to 85.6%, alongside improved platinum group metal grades and recoveries, potentially reshaping project economics.

SPC Global reported solid Q4 FY26 growth driven by domestic beverage sales and a 50.8% jump in international revenue, while a $100 million equity raise slashed net leverage and paved the way for improved cash flow in FY27.

European Metals Holdings has revealed preliminary testwork results indicating a potential switch to a tunnel kiln for its Cinovec Lithium Project, promising substantial capital and operating cost savings alongside a reduced carbon footprint.

Spacetalk has inked a strategic MVNO deal with TPG Telecom, aiming to improve mobile service economics and accelerate subscriber growth as it shifts towards a software-led business model.

Prophecy International has launched a sweeping global organisational restructure that will slash its workforce by approximately 48%, aiming to realign operations and reduce costs ahead of its FY26 results.

OncoSil Medical secures a spot in the PALACROS consortium, advancing its OncoSil™ device through a cost-efficient Phase II trial targeting unresectable locally advanced pancreatic cancer.

Imricor Medical Systems expands its US market reach with FDA 510(k) clearances for pediatric use of its NorthStar system and Vision-MR Diagnostic Catheter, enabling radiation-free cardiac catheterisations for children.

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.